Autonomic Nervous System Drugs Practice Questions

Q: Drug H is most like which of the following agents?

Epinephrine. ***Epinephrine*** - Drug H demonstrates activity at **all adrenergic receptor subtypes** (α1, α2, β1, β2), which perfectly matches **epinephrine's broad receptor profile**. - Epinephrine is a **non-selective adrenergic agonist** that activates both **alpha and beta receptors** with equal potency, producing diverse physiological effects. *Isoproterenol* - Acts as a **selective β-adrenergic agonist** (β1 and β2) with **no alpha receptor activity**. - Would not match Drug H's profile since it lacks **α1 and α2 receptor stimulation**. *Norepinephrine* - Primarily activates **α1, α2, and β1 receptors** but has **minimal β2 activity**. - Differs from Drug H because it shows **weak or absent β2 receptor stimulation**. *Phenylephrine* - Functions as a **selective α1-adrenergic agonist** with **no beta receptor activity**. - Cannot match Drug H's profile due to complete absence of **β1 and β2 receptor stimulation**.

Q: Which of the following drugs is used as a diagnostic tool?

Tensilon. **Explanation:** **Tensilon (Edrophonium)** is the correct answer because it is a classic diagnostic tool used in the **Tensilon Test** for **Myasthenia Gravis (MG)**. Edrophonium is a very short-acting reversible acetylcholinesterase inhibitor. By inhibiting the breakdown of acetylcholine at the neuromuscular junction, it temporarily increases the concentration of the neurotransmitter. In patients with MG, this leads to a rapid, transient improvement in muscle strength (especially ptosis), confirming the diagnosis. **Analysis of Incorrect Options:** * **Cevimeline (A):** This is a synthetic muscarinic agonist (M1 and M3 selective) used primarily for the **treatment** of xerostomia (dry mouth) in Sjögren’s syndrome, not for diagnosis. * **Vedolizumab (B):** This is a monoclonal antibody that binds to α4β7 integrin. It is used as a **therapeutic** agent in the management of inflammatory bowel diseases like Crohn’s disease and Ulcerative Colitis. * **Sacubitril (D):** This is a neprilysin inhibitor used in **combination with Valsartan (ARNI)** for the treatment of chronic heart failure with reduced ejection fraction. **High-Yield Clinical Pearls for NEET-PG:** * **Tensilon Test:** Due to the risk of bradycardia or bronchospasm during the test, **Atropine** should always be kept ready as an antidote. * **Differentiation:** Edrophonium is also used to differentiate between a **Myasthenic Crisis** (improvement with Tensilon) and a **Cholinergic Crisis** (worsening with Tensilon). * **Current Trend:** While historically high-yield, the Tensilon test is being replaced in modern practice by Ice Pack tests and MuSK/AChR antibody titers due to the risk of cardiac side effects.

Q: Which of the following is a non-depolarizing blocking agent?

Pancuronium. ### Explanation Neuromuscular blocking agents (NMBAs) are classified into two main categories based on their mechanism of action at the nicotinic acetylcholine receptors ($N_m$) of the motor endplate: **Depolarizing** and **Non-depolarizing** blockers [1], [2]. **1. Why Pancuronium is Correct:** **Pancuronium** is a long-acting **non-depolarizing neuromuscular blocker** belonging to the aminosteroid group [3]. It acts as a competitive antagonist; it binds to $N_m$ receptors without activating them, thereby preventing acetylcholine from triggering muscle contraction. This results in flaccid paralysis [2]. **2. Analysis of Incorrect Options:** * **Suxamethonium (Succinylcholine):** This is the prototype **depolarizing** blocker [1]. It acts as an agonist at $N_m$ receptors, causing persistent depolarization (often seen as initial fasciculations) followed by paralysis [2]. It is the drug of choice for rapid sequence intubation due to its short duration of action. * **Decamethonium:** Another **depolarizing** agent. It is rarely used clinically today but is historically significant in pharmacology. * **Baclofen (Beclofen):** This is a **centrally acting muscle relaxant**. It is a $GABA_B$ agonist used to treat spasticity (e.g., in multiple sclerosis). It does not act at the neuromuscular junction and is not a "blocking agent" in the context of anesthesia. **3. NEET-PG High-Yield Pearls:** * **Antidote:** Non-depolarizing blocks can be reversed with Acetylcholinesterase inhibitors (e.g., **Neostigmine**) or **Sugammadex** (specifically for Rocuronium/Vecuronium). * **Side Effects:** Pancuronium can cause **tachycardia** due to its vagolytic effect by blocking cardiac mAChRs [3]. * **Hoffman Elimination:** Remember **Atracurium** and **Cisatracurium** undergo spontaneous degradation (Hoffman elimination), making them safe in renal or hepatic failure. * **Mnemonic:** Non-depolarizing agents often end in **"-curium"** or **"-curonium"**.

Q: Botulinum toxin affects all of the following except:

Central Nervous System. **Explanation:** Botulinum toxin, produced by *Clostridium botulinum*, acts by cleaving **SNARE proteins** (specifically Synaptobrevin, SNAP-25, and Syntaxin). This prevents the fusion of synaptic vesicles with the presynaptic membrane, thereby inhibiting the release of **Acetylcholine (ACh)** at all cholinergic nerve terminals. **Why the Central Nervous System (CNS) is the correct answer:** Botulinum toxin is a large protein molecule that **cannot cross the blood-brain barrier (BBB)**. Therefore, when administered systemically or locally, it does not affect the CNS. Its effects are strictly limited to the peripheral nervous system. **Analysis of Incorrect Options:** * **Neuromuscular Junction (NMJ):** This is the primary site of action. By blocking ACh release at the NMJ, the toxin causes flaccid paralysis (the hallmark of botulism). * **Preganglionic Junctions:** All preganglionic fibers (both sympathetic and parasympathetic) are cholinergic. The toxin effectively blocks transmission at these autonomic ganglia. * **Post-ganglionic Nerves:** All parasympathetic post-ganglionic nerves and sympathetic post-ganglionic nerves supplying sweat glands are cholinergic. These are susceptible to the toxin, leading to autonomic symptoms like dry mouth and anhidrosis. **NEET-PG High-Yield Pearls:** * **Mechanism:** Proteolysis of SNARE proteins (Irreversible inhibition). * **Clinical Uses:** Strabismus, blepharospasm, achalasia cardia, spasticity, and cosmetic reduction of wrinkles. * **Antidote:** Toxin effects are permanent at the specific nerve terminal; recovery requires the sprouting of new nerve terminals (axonal regrowth). * **Contrast:** Unlike Botulinum (which blocks release), **Tetanus toxin** undergoes retrograde axonal transport to the CNS, where it inhibits GABA/Glycine release, causing spastic paralysis.

Q: What is the first-line drug for angle closure glaucoma?

Acetazolamide. **Explanation:** Acute Angle-Closure Glaucoma (AACG) is an ophthalmic emergency characterized by a sudden rise in intraocular pressure (IOP) due to the blockage of aqueous humor outflow. **Why Acetazolamide is the Correct Answer:** Acetazolamide, a potent **Carbonic Anhydrase Inhibitor (CAI)**, is the first-line systemic treatment for the immediate management of AACG. It works by inhibiting the enzyme carbonic anhydrase in the ciliary body, which rapidly decreases the production of aqueous humor. In an emergency, it is typically administered intravenously (or orally) to lower IOP quickly before definitive surgical or laser treatment (like peripheral iridotomy) can be performed. **Analysis of Incorrect Options:** * **Physostigmine:** While miotics (like Pilocarpine) are used in glaucoma to pull the iris away from the angle, Physostigmine is a reversible anticholinesterase not typically used as a first-line agent for acute closure. Furthermore, miotics are often ineffective until the IOP is first lowered by CAIs. * **Brimonidine:** This is an alpha-2 agonist used primarily in chronic open-angle glaucoma or as an adjunctive therapy. It is not the primary drug for an acute emergency. * **Atropine:** This is **contraindicated**. As a mydriatic (dilator), it causes the iris to bunch up in the drainage angle, further obstructing outflow and potentially precipitating or worsening an attack of angle-closure glaucoma. **Clinical Pearls for NEET-PG:** * **Definitive Treatment:** The definitive treatment for AACG is **Laser Peripheral Iridotomy**. * **Hyperosmotics:** Intravenous **Mannitol** is another emergency agent used if IOP does not respond to Acetazolamide. * **Side Effects:** Watch for hypokalemia, metabolic acidosis, and paresthesia with Acetazolamide use. * **Avoid Mydriatics:** Always remember that drugs with anticholinergic properties (like Atropine or TCAs) can trigger AACG in predisposed individuals with narrow angles.

Q: Which drug is used to treat dry mouth (xerostomia) in patients undergoing cancer chemotherapy?

Cevimeline. **Explanation:** **Cevimeline** is the preferred drug for treating xerostomia (dry mouth) associated with Sjögren’s syndrome or radiation/chemotherapy-induced salivary gland dysfunction. It is a **selective M3 muscarinic agonist**. Since M3 receptors are primarily responsible for stimulating salivary and lacrimal secretions, Cevimeline effectively increases saliva production. Compared to other cholinergic drugs, it has a longer duration of action and a better side-effect profile due to its relative selectivity. **Analysis of Incorrect Options:** * **Oxotremorine (A):** This is a potent muscarinic agonist but is primarily used as a research tool to induce parkinsonian-like tremors in animal models. It has no clinical application in treating xerostomia. * **Methacholine (B):** This is a non-selective muscarinic agonist. Its clinical use is restricted to the **Methacholine Challenge Test** for diagnosing bronchial hyperreactivity (Asthma). It is not used for xerostomia due to its significant cardiovascular and pulmonary side effects. * **Pilocarpine (D):** While Pilocarpine *is* used to treat xerostomia, it is a non-selective muscarinic agonist (M1, M2, M3). It has a shorter half-life than Cevimeline and more frequent side effects (sweating, flushing, and urinary urgency). In many clinical scenarios, Cevimeline is favored for its M3 selectivity. **NEET-PG High-Yield Pearls:** * **M3 Receptors:** Located on exocrine glands (sweat, salivary, lacrimal) and smooth muscles (bronchi, bladder, gut). * **Drug of Choice:** Cevimeline is often cited as the drug of choice for Sjögren’s syndrome-related dry mouth. * **Contraindications:** Muscarinic agonists should be avoided in patients with uncontrolled asthma, COPD, or acute iritis. * **Pilocarpine** remains the drug of choice for **Acute Angle Closure Glaucoma** (miotic agent).

Question 1

Drug H is most like which of the following agents?

Accepted Answer

Epinephrine

Answer

Isoproterenol

Answer

Norepinephrine

Answer

Phenylephrine

Question 2

Which of the following drugs is used as a diagnostic tool?

Accepted Answer

Tensilon

Answer

Cevimeline

Answer

Vedolizumab

Answer

Sacubitril

Question 3

Which of the following is a non-depolarizing blocking agent?

Accepted Answer

Pancuronium

Answer

Suxamethonium

Answer

Decamethonium

Answer

Beclofen

Question 4

What is the overall action of caffeine on heart rate?

Accepted Answer

Decreases

Answer

Increases

Answer

No effect

Answer

First increases then decreases

Question 5

Botulinum toxin affects all of the following except:

Accepted Answer

Central Nervous System

Answer

Neuromuscular junction

Answer

Preganglionic junction

Answer

Post-ganglionic nerves

Question 6

Which of the following provides the best explanation for neostigmine being preferred over physostigmine for treating Myasthenia gravis?

Accepted Answer

Neostigmine has an additional direct agonistic action on the nicotinic receptor in the muscle end plate.

Answer

Neostigmine is better absorbed orally.

Answer

Neostigmine has a longer duration of action.

Answer

Neostigmine penetrates the blood-brain barrier.

Question 7

What is the first-line drug for angle closure glaucoma?

Accepted Answer

Acetazolamide

Answer

Physostigmine

Answer

Brimonidine

Answer

Atropine

Question 8

Botulinum toxin blocks neuromuscular transmission by which mechanism?

Accepted Answer

Closure of Ca++ channels at the presynaptic membrane

Answer

Closure of Na+ channels at the postsynaptic membrane

Answer

Opening of K+ channels at the presynaptic membrane

Answer

Opening of Cl- channels at the postsynaptic membrane

Question 9

Which drug is used to treat dry mouth (xerostomia) in patients undergoing cancer chemotherapy?

Accepted Answer

Cevimeline

Answer

Oxotremorine

Answer

Methacholine

Answer

Pilocarpine

Question 10

Which of the following muscle relaxants possesses ganglion blocker action?

Accepted Answer

Halothane

Answer

Pancuronium

Answer

Trimethaphan

Answer

Curare

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?